Abstract: Nucleoside diphosphate kinases (NDPK) are key enzymes involved in the intracellular nucleotide maintenance in all living organisms, especially in trypanosomatids which are unable to synthesise purines de novo. Four putative NDPK isoforms were identified in the Trypanosoma cruzi Chagas, 1909 genome but only two of them were characterised so far. In this work, we studied a novel isoform from T. cruzi called TcNDPK3. This enzyme presents an atypical N-terminal extension similar to the DM10 domains. In T. cruzi, DM10 sequences targeted other NDPK isoform (TcNDPK2) to the cytoskeleton, but TcNDPK3 was localised in glycosomes despite lacking a typical peroxisomal targeting signal. In addition, TcNDPK3 was found only in the bloodstream trypomastigotes where glycolytic enzymes are very abundant. However, TcNDPK3 mRNA was also detected at lower levels in amastigotes suggesting regulation at protein and mRNA level. Finally, 33 TcNDPK3 gene orthologs were identified in the available kinetoplastid genomes. The characterisation of new glycosomal enzymes provides novel targets for drug development to use in therapies of trypanosomatid associated diseases.
Nucleoside diphosphate kinases (NDPK) are enzymes involved in the intracellular nucleotide balance that catalyse the reversible transference of high-energy phosphates from a nucleoside triphosphate donor to a nucleoside diphosphate acceptor (Veron et al. 1994) . In trypanosomatid parasites NDPKs are key enzymes due to their inability to synthesise purines de novo and thus they depend on NDPKs for nucleotide recycling (Berriman et al. 2005 ). This essential function allows considering NDPKs as potential therapeutic targets for trypanosomiasis.
Trypanosoma cruzi Chagas, 1909 has four isoforms of NDPK, two of them well characterised (TcNDPK1 and Tc-NDPK2) and other uncharacterised putative isoforms . TcNDPK1 is the canonical short isoform, whereas TcNDPK2, TcNDPK3 and TcNDPK4 correspond to the 'long' isoform variants. Isoforms 2 and 3 have one DM10 domain preceding the catalytic region and variant 4 has unknown N-and C-terminal extensions (Miranda et al. 2008a (Miranda et al. , 2011 . NDPK activity in trypanosomatids was first described by Ulloa et al. (1995) detecting NDPK activity in some subcelular fractions including membranes. These authors also purified a soluble NDPK with similar characteristics to TcNDPK1. TcNDPK1 is a hexameric enzyme (Gomez Barroso et al. 2010 ) expressed mainly in trypomastigote and amastigote stages of the T. cruzi life cycle.
This isoform also showed DNAse activity (Miranda et al. 2008b) , which was extensively characterised in NM23-H2, the human orthologous of TcNDPK1 (Postel 2003) . As genomic DNA of T. cruzi was degraded by Tc-NDPK1 nuclease activity, this isoform could act at nuclear level as a component of programmed cell death machinery or DNA repair systems (Debrabant and Nakhasi 2003, Hammargren et al. 2007) . In this sense, the Trypanosoma brucei gene orthologous of TcNDPK1 was localised in the parasites nucleus (Hunger-Glaser et al. 2000) and also in secreted parasite microvesicles (Geiger et al. 2010) . In addition, the Leishmania spp. gene orthologous was associated to microsomal fractions and it was found to be secreted regulating macrophage infection (de Oliveira et al. 2006 , Kolli et al. 2008 .
In TcNDPK1 of T. cruzi has a cytosolic perinuclear distribution and, in a subpopulation of epimastigotes under metacyclogenesis and metacyclic trypomastigotes, was localised in non-membrane bounded granules adjacent to the nucleus (Pereira et al. 2014) . TcNDPK2 was localised in cytoskeleton and flagella, detected in polymerised tubulin. Additionally, it has been demonstrated that the DM10 domain is responsible for TcNDPK2 microtubule association (Miranda et al. 2011) . In this work we identified for the first time a nucleoside diphosphate kinase of T. cruzi localised in glycosome which is predominantly expressed in bloodstream trypomastigotes.
MATERIALS AND METHODS

Cell cultures
Epimastigotes of Y (DTU Trypanosoma cruzi II) were cultured at 28 °C in plastic flasks (25 cm 2 ), containing 5 ml of Brain Heart Tryptose medium (started with 10 6 cells per millilitre) supplemented with 10% fetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin (Camargo 1964) . The parasites were subcultured with passages each 7 days. Cells were counted using a hemocytometer.
Fluorescence microscopy
Epimastigote samples from the days 1-7 after transfection were washed twice with PBS. After letting the cells settle for 30 min at room temperature onto poly-L-lysine coated coverslips, parasites were fixed at room temperature for 20 min with 4% formaldehyde in PBS, followed by a cold methanol treatment for 5 min. Parasites were washed with PBS and incubated with polyclonal TcNDPK3 antibodies (1 : 200), followed by Alexa Fluor ® 488-conjugated secondary antibody and slides were mounted using Vectashield with DAPI (Vector Laboratories, Burlingame, CA, USA). Cells were observed in an Olympus BX60 fluorescence microscope. Images were recorded with an Olympus XM10 camera.
Western blot analysis
Western blots were performed using total extracts of T. cruzi, fractioned by electrophoresis in polyacrylamide denaturing gels, and transferred to polyvinylidene fluoride (PVDF) membranes. The PVDF membranes were treated for 1 h with 5% non-fat dry milk in PBS and then incubated with the corresponding primary antibody overnight, (anti-TcNDPK3 diluted 1 : 2,000 or anti-polyHistidine 1 : 3,000; Sigma-Aldrich, St. Louis, MO, USA). Membranes were washed and incubated with the secondary antibody for 2 h (anti-mouse HRP 1 : 2,500, Vector Laboratories). Detection was done by chemiluminescence (Pierce Biotechnology, Rockford, IL, USA).
Nucleoside diphosphate kinase activity
NDPK activity was measured using the purified TcNDPK3 recombinant protein. This protein was produced using cells of Escherichia coli transformed with an expression plasmid containing the TcNDPK3 fused to a 6His tag (pRSET-6His::TcNDPK3). The production was induced with 0.1mM IPTG for 4 h. Since the protein was obtained aggregated in inclusion bodies, first these were resuspended in 50 mM Tris-HCl buffer (pH 8), 100 mM NaCl and 6 M urea. Then, the solution was diluted in the same buffer until reaching 1 M urea. Finally, the protein was purified using an affinity purification resin (Ni Sepharose™ 6 Fast Flow, GE Healthcare, Chicago, IL, USA). The activity was measured as previously reported (Miranda et al. 2008a) . Briefly, 1.5 µg of TcNDPK3 recombinant protein was added to the reaction mixture (100 mM Tris-HCl buffer, pH 7.5, 3 mM phosphoenolpyruvate, 10 mM MgCl 2 , 0.3 mM NADH, 25 mM KCl, 1.25 U/ml pyruvate kinase and 2.2 U ml lactate dehydrogenase) in a cuvette to give a final volume of 0.5 ml. After 5 min at 35 °C the reaction was started by the addition of a small volume of ATP and dTDP to final concentrations of 2 mM and 0.1-4 mM, respectively. The activity was calculated measuring the decrease in absorbance at 340 nm due to the oxidation of NADH.
RNA extraction and Real time PCR assays
Epimastigote, trypomastigote and amastigote cells were harvested by centrifugation, washed with PBS and resuspended in 1 ml of Tri-Reagent (Sigma), mixed by inversion and 200 µl of chloroform was added followed by centrifugation at 12,000 g at 4 °C. The supernatant was transferred to a clean test tube and 500 ml of isopropanol was added; after 10 min of incubation at room temperature, cells were centrifuged at 12,000 g for 15 min. The pellet was washed with ethanol to 75%, left to dry and resuspended in 20 µl of RNase-free water. RNA concentrations were determined spectrophotometrically and purity was confirmed by gel electrophoresis; 3 µg of RNA were used for retrotranscription. Before retrotranscription, samples were treated with DNase I (Sigma). TcNDPK3 mRNA expression in the major T. cruzi life cycle stages was quantified by SYBR green-based real-time PCR in a Real-Time PCR system (Thermo Fisher Scientific, Waltham, MA, USA) using default protocols. Data were normalised to 18S ribosomal RNA expression. Three independent experiments were carried out, for each every three independent samples.
Bioinformatics
Sequences from the TriTryp genome projects were obtained at TriTrypDB (http://tritrypdb.org/) and GeneDB (http://www. genedb.org/). Analysis of the DNA sequence data were carried out using the software package Vector NTI v. 10.3.0 (Invitrogen, Carlsbad, CA, USA) and the online version of BLAST at the NCBI (http://www.ncbi.nlm.nih.gov/). Local or online software were used under default parameters. Phylogenetic analysis was performed using MEGA v6 (Tamura et al. 2013) .
RESULTS
Cloning, overexpression and functional validation of TcNDPK3. The predicted TcNDPK3 is a 349 amino acid long protein with an isoelectric point of 5.2 and a molecular weight of about 39.3 kDa. To test if TcNDPK3 is a bona fide nucleoside diphosphate kinase, the gene was fused to a x6His tag (2.5 kDa), cloned and expressed in Escherichia coli. The affinity purified recombinant protein showed in the SDS-PAGE (Fig. S1A,B) has a predicted molecular weight of 41.8 kDa. The functionality of the purified recombinant nucleoside diphosphate kinase was fully confirmed by standard enzymatic activity using an enzymes coupled assay by the production of ADP using dTDP and ATP as substrates (Fig. 1) . The enzyme presented a Michaelis-Menten kinetics, with Km = 1.1 mM and Fig. 1 . Functional validation of Trypanosoma cruzi nucleoside diphosphate kinase 3 (TcNDPK3). Different dTDP concentrations (0.1-4 mM) were evaluated in order to obtain the TcNDPK3 kinetic parameters based on ADP production from dTDP and ATP as substrates. The assays were performed during 10 min using 1.5 µg of recombinant protein. Using these 118 genes a Maximum Likelihood phylogenetic tree was constructed ( Fig. 2A) . In the resulting unrooted phylogenetic tree it can be clearly seen the four clusters of the gene orthologs of the different isoforms of NDPK. Tc-NDPK1, the canonical isoform, grouped the higher number of genes (41), TcNDPKs possessing the N-terminal DM10 domains (TcNDPK2 and TcNDPK3; Fig. 2B ) have a similar number of orthologs (32-33), and the other 'long' putative isoform of TcNDPK (TcNDPK4) has only 12 gene orthologs. Within the four isoforms of Trypanosoma cruzi NDPKs, TcNDPK4 is the only one not yet functionally validated.
Expression of TcNDPK3 during the life cycle of Trypanosoma cruzi. TcNDPK3 expression was evaluated in the main stages of the life cycle of T. cruzi. Western blot analysis were performed using anti-TcNDPK3 specific antibodies and total extract samples from epimastigotes, trypomastigotes and amastigotes. TcNDPK3 signal was detected exclusively in bloodstream trypomastigote samples (Fig. 3A) . To further confirm these results the abundance of TcNDPK3 mRNA in the three stages was quantified by real time PCR (Fig. S2) . The relative amounts of TcNDPK3 mRNA were calculated and expressed as arbitrary units (AU). Epimastigotes samples have 0.9 AU, whereas trypomastigotes and amastigotes samples have 10.9 AU and 6.1 AU, respectively. These results indicate that TcNDPK3 has a stage-specific regulation and its expression is partially modulated at mRNA level.
Subcellular localisation of TcNDPK3. Among the nucleoside diphosphate kinase family of T. cruzi, TcNDPK2 is the only isoform that possesses a functionally characterised N-terminal DM10 domain which is similar to the one present in TcNDPK3 with about 50% of consensus positions (Fig. 2B ). This data suggests that, like TcNDPK2, TcNDPK3 could be also associated to the cytoskeleton. To test this hypothesis, trypomastigote samples were analysed by immunofluorescence techniques using anti-TcNDPK3 antibodies. Interestingly, no signal was observed in the cytoskeleton, but fluorescence was located in multiple glycosome-like organelles. To further confirm these data, colocalisation analysis was performed using anti-hexokinase antibodies as glycosomal marker (Cazzulo 1992 ). As figure 3B shows, TcNDPK3 colocalises with hexokinase demonstrating that this NDPK isoform is present in glycosomes.
DISCUSSION
In this work we report for the first time the presence of a nucleoside diphosphate kinase in glycosomes, which is expressed only in the mammalian parasite stage trypomastigote. This could be explained because, in contrast to the insect stage, glycolytic enzymes are very abundant in bloodstream stages of mammalian trypanosomatids, which rely mainly on glycolysis and substrate-level phosphorylation for the generation of energy (Clayton and Michels 1996) . In addition, the enzymatic content of glycosomes is rapidly changed during parasite stage differentiation (Michels et al. 2006) . Although TcNDPK3 role in the glycosome is not obvious, it could be related to the nucleotide balance linked to the exchange across the membrane by specific nucleotide transporters. Nevertheless, if this is the actual TcNDPK3 function it may be exclusive for Trypanosoma cruzi as no NDPK3-like protein have been found in glycosomal proteomes in other trypanosomatid organisms.
An other singular feature of TcNDPK3 is the apparent absence of known peroxisomal targeting signals (PTS). However, the subcellular localisation could be related with the quaternary structure of the protein, since many NDPKs have shown to form homohexamers. Using prediction programs, TcNDPK3 has low expected values for the con- Fig. 3 . Trypanosoma cruzi nucleoside diphosphate 3 (TcNDPK3) expression analysis and subcellular localisation. A -Western blots were performed using samples from the main stages of the life cycle of Trypanosoma cruzi, epimastigotes (E), trypomastigotes (T) and amastigotes (A). Upper panel was revealed using anti-TcNDPK3 antibodies (N3) and the lower panel using anti-tubulin antibodies as loading control (TUB). Molecular weights are also indicated; B -immunofluorescence microscopy was performed using samples of trypomastigotes and anti-TcNDPK3 antibodies (N3), anti-hexokinase antibodies (HK), DAPI staining and differential interference contrast (DIC). TcNDPK3 and hexokinase signals were merged to detect the colocalisation of both enzymes (MERGE).
A B
A sensus sequences PTS1, PTS2 and Pex19, suggesting other localisation signals which were not yet identified. The putative role of the DM10 domain in TcNDPK3 localisation could not be tested because the parasites that express this domain fused to a fluorescence marker or a truncated Tc-NDPK3 have a lethal phenotype (data not shown). Therefore, further studies are required to confirm the DM10 domain function in this protein. Since TcNDPK2 is associated with microtubules and it has the DM10 domain, TcNDPK3 could be located inside glycosomes or could be bound to the outside of the organelle in association with any specific structure. TcNDPK3 seems to be regulated at mRNA and protein levels since the mRNA quantified by RT-PCR was detected mainly in trypomastigote but also in samples of amastigotes, unlike the protein that was present exclusively in trypomastigotes.
The evolutionary importance of TcNDPK3 is reflected in its conservation among different kinetoplastid organisms
as it is the second most represented isoform with 33 gene orthologs. Other phosphotransferase enzymes involved in nucleotide homeostasis have been previously identified in trypanosomatid glycosomes, for example the adenylate kinase isoforms 3 and D in T. cruzi and T. brucei, respectively (Ginger et al. 2005 , Cámara et al. 2012 ) and the arginine kinase isoform 2 in T. brucei (Voncken et al. 2013) . Despite conservation throughout the evolution of a wide variety of phosphotransferases in glycosomes, their function in this organelle still remains unknown. In addition, two human TcNDPK3 gene homologs were identified, corresponding to the nucleoside diphosphate kinase 7 isoforms A and B (GeneBank IDs: NP_037462.1 and NP_932076.1, respectively). Both human isoforms were associated to the risk of venous thromboembolism risk; however, there is also no information about the function of these enzymes (Heit et al. 2012) . Interestingly, the NDPK3 from T. cruzi showed the lowest affinity for its substrate dTDP when compared with the NDPKs from other organisms, with a Km 3-5 times higher than the reported for the human NDPKs. These differences in kinetics may suggest dissimilar functionalities in each organism that could be exploited for drug design.
Considering that glycosomes are present only in kinetoplastid, the identification of new enzymes of this organelle constitutes an important step for the development of new therapies for trypanosomatid-associated diseases.
